BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31726225)

  • 21. Reader interactome of epigenetic histone marks in birds.
    Bluhm A; Casas-Vila N; Scheibe M; Butter F
    Proteomics; 2016 Feb; 16(3):427-36. PubMed ID: 26703087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered bromodomains to explore the acetylproteome.
    Bryson BD; Del Rosario AM; Gootenberg JS; Yaffe MB; White FM
    Proteomics; 2015 May; 15(9):1470-5. PubMed ID: 25641834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins.
    Taniguchi Y
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromodomains: Structure, function and pharmacology of inhibition.
    Ferri E; Petosa C; McKenna CE
    Biochem Pharmacol; 2016 Apr; 106():1-18. PubMed ID: 26707800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bromodomain interaction module.
    Filippakopoulos P; Knapp S
    FEBS Lett; 2012 Aug; 586(17):2692-704. PubMed ID: 22710155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polybromo-1-bromodomains bind histone H3 at specific acetyl-lysine positions.
    Chandrasekaran R; Thompson M
    Biochem Biophys Res Commun; 2007 Apr; 355(3):661-6. PubMed ID: 17320048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein lysine acetylation and its role in different human pathologies: a proteomic approach.
    Morales-Tarré O; Alonso-Bastida R; Arcos-Encarnación B; Pérez-Martínez L; Encarnación-Guevara S
    Expert Rev Proteomics; 2021 Nov; 18(11):949-975. PubMed ID: 34791964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Subset of Human Bromodomains Recognizes Butyryllysine and Crotonyllysine Histone Peptide Modifications.
    Flynn EM; Huang OW; Poy F; Oppikofer M; Bellon SF; Tang Y; Cochran AG
    Structure; 2015 Oct; 23(10):1801-1814. PubMed ID: 26365797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological function and histone recognition of family IV bromodomain-containing proteins.
    Lloyd JT; Glass KC
    J Cell Physiol; 2018 Mar; 233(3):1877-1886. PubMed ID: 28500727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bromodomains and their pharmacological inhibitors.
    Gallenkamp D; Gelato KA; Haendler B; Weinmann H
    ChemMedChem; 2014 Mar; 9(3):438-64. PubMed ID: 24497428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tandem bromodomains in the chromatin remodeler RSC recognize acetylated histone H3 Lys14.
    Kasten M; Szerlong H; Erdjument-Bromage H; Tempst P; Werner M; Cairns BR
    EMBO J; 2004 Mar; 23(6):1348-59. PubMed ID: 15014446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional Roles of Bromodomain Proteins in Cancer.
    Boyson SP; Gao C; Quinn K; Boyd J; Paculova H; Frietze S; Glass KC
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional networks of the human bromodomain-containing proteins.
    Gao C; Glass KC; Frietze S
    Front Bioinform; 2022; 2():835892. PubMed ID: 36304339
    [No Abstract]   [Full Text] [Related]  

  • 34. The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators.
    Wai DCC; Szyszka TN; Campbell AE; Kwong C; Wilkinson-White LE; Silva APG; Low JKK; Kwan AH; Gamsjaeger R; Chalmers JD; Patrick WM; Lu B; Vakoc CR; Blobel GA; Mackay JP
    J Biol Chem; 2018 May; 293(19):7160-7175. PubMed ID: 29567837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular dynamics for computational proteomics of methylated histone H3.
    Grauffel C; Stote RH; Dejaegere A
    Biochim Biophys Acta; 2015 May; 1850(5):1026-1040. PubMed ID: 25240462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer.
    Hsu CC; Shi J; Yuan C; Zhao D; Jiang S; Lyu J; Wang X; Li H; Wen H; Li W; Shi X
    Genes Dev; 2018 Jan; 32(1):58-69. PubMed ID: 29437725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay.
    Lu T; Hu JC; Lu WC; Han J; Ding H; Jiang H; Zhang YY; Yue LY; Chen SJ; Jiang HL; Chen KX; Chai HF; Luo C
    Acta Pharmacol Sin; 2018 Sep; 39(9):1544-1552. PubMed ID: 29795359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural insights into acetylated histone ligand recognition by the BDP1 bromodomain of Plasmodium falciparum.
    Singh AK; Phillips M; Alkrimi S; Tonelli M; Boyson SP; Malone KL; Nix JC; Glass KC
    Int J Biol Macromol; 2022 Dec; 223(Pt A):316-326. PubMed ID: 36328269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical Proteomic Profiling of Bromodomains Enables the Wide-Spectrum Evaluation of Bromodomain Inhibitors in Living Cells.
    Li X; Wu Y; Tian G; Jiang Y; Liu Z; Meng X; Bao X; Feng L; Sun H; Deng H; Li XD
    J Am Chem Soc; 2019 Jul; 141(29):11497-11505. PubMed ID: 31246451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small molecule inhibitors of bromodomain-acetyl-lysine interactions.
    Brand M; Measures AR; Wilson BG; Cortopassi WA; Alexander R; Höss M; Hewings DS; Rooney TP; Paton RS; Conway SJ
    ACS Chem Biol; 2015 Jan; 10(1):22-39. PubMed ID: 25549280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.